Skip to main content
Top
Published in: BMC Immunology 1/2011

Open Access 01-12-2011 | Research article

Cytokine expression during early and late phase of acute Puumala hantavirus infection

Authors: Mahmoud Sadeghi, Isabella Eckerle, Volker Daniel, Ulrich Burkhardt, Gerhard Opelz, Paul Schnitzler

Published in: BMC Immunology | Issue 1/2011

Login to get access

Abstract

Background

Hantaviruses of the family Bunyaviridae are emerging zoonotic pathogens which cause hemorrhagic fever with renal syndrome (HFRS) in the Old World and hantavirus pulmonary syndrome (HPS) in the New World. An immune-mediated pathogenesis is discussed for both syndromes. The aim of our study was to investigate cytokine expression during the course of acute Puumala hantavirus infection.

Results

We retrospectively studied 64 patients hospitalised with acute Puumala hantavirus infection in 2010 during a hantavirus epidemic in Germany. Hantavirus infection was confirmed by positive anti-hantavirus IgG/IgM. Cytokine expression of IL-2, IL-5, IL-6, IL-8, IL-10, IFN-γ, TNF-α and TGF-β1 was analysed by ELISA during the early and late phase of acute hantavirus infection (average 6 and 12 days after onset of symptoms, respectively). A detailed description of the demographic and clinical presentation of severe hantavirus infection requiring hospitalization during the 2010 hantavirus epidemic in Germany is given. Acute hantavirus infection was characterized by significantly elevated levels of IL-2, IL-6, IL-8, TGF-β1 and TNF-α in both early and late phase compared to healthy controls. From early to late phase of disease, IL-6, IL-10 and TNF-α significantly decreased whereas TGF-β1 levels increased. Disease severity characterized by elevated creatinine and low platelet counts was correlated with high pro-inflammatory IL-6 and TNF-α but low immunosuppressive TGF-β1 levels and vice versa .

Conclusion

High expression of cytokines activating T-lymphocytes, monocytes and macrophages in the early phase of disease supports the hypothesis of an immune-mediated pathogenesis. In the late phase of disease, immunosuppressive TGF-β1 level increase significantly. We suggest that delayed induction of a protective immune mechanism to downregulate a massive early pro-inflammatory immune response might contribute to the pathologies characteristic of human hantavirus infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jonsson CB, Figueiredo LT, Vapalahti O: A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010, 23: 412-441. 10.1128/CMR.00062-09.PubMedPubMedCentralCrossRef Jonsson CB, Figueiredo LT, Vapalahti O: A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010, 23: 412-441. 10.1128/CMR.00062-09.PubMedPubMedCentralCrossRef
2.
go back to reference Muranyi W, Bahr U, Zeier M, van der Woude FJ: Hantavirus infection. J Am Soc Nephrol. 2005, 16: 3669-3679. 10.1681/ASN.2005050561.PubMedCrossRef Muranyi W, Bahr U, Zeier M, van der Woude FJ: Hantavirus infection. J Am Soc Nephrol. 2005, 16: 3669-3679. 10.1681/ASN.2005050561.PubMedCrossRef
3.
go back to reference Christou L: The global burden of bacterial and viral zoonotic infections. Clin Microbiol Infect. 2011, 17: 326-330. 10.1111/j.1469-0691.2010.03441.x.PubMedCrossRef Christou L: The global burden of bacterial and viral zoonotic infections. Clin Microbiol Infect. 2011, 17: 326-330. 10.1111/j.1469-0691.2010.03441.x.PubMedCrossRef
4.
go back to reference Settergren B, Juto P, Wadell G, Trollfors B, Norrby SR: Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden. Am J Epidemiol. 1988, 127: 801-807.PubMed Settergren B, Juto P, Wadell G, Trollfors B, Norrby SR: Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden. Am J Epidemiol. 1988, 127: 801-807.PubMed
5.
go back to reference Faber MS, Ulrich RG, Frank C, Brockmann SO, Pfaff GM, Jacob J, Kruger DH, Stark K: Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill. 2010, 15: Faber MS, Ulrich RG, Frank C, Brockmann SO, Pfaff GM, Jacob J, Kruger DH, Stark K: Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill. 2010, 15:
6.
go back to reference Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis. 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6.PubMedCrossRef Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis. 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6.PubMedCrossRef
7.
go back to reference Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietila K, Vaheri A: Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994, 26: 7-13. 10.3109/00365549409008583.PubMedCrossRef Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietila K, Vaheri A: Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994, 26: 7-13. 10.3109/00365549409008583.PubMedCrossRef
8.
go back to reference Sinisalo M, Vapalahti O, Ekblom-Kullberg S, Laine O, Makela S, Rintala H, Vaheri A: Headache and low platelets in a patient with acute leukemia. J Clin Virol. 2010, 48: 159-161. 10.1016/j.jcv.2010.02.015.PubMedCrossRef Sinisalo M, Vapalahti O, Ekblom-Kullberg S, Laine O, Makela S, Rintala H, Vaheri A: Headache and low platelets in a patient with acute leukemia. J Clin Virol. 2010, 48: 159-161. 10.1016/j.jcv.2010.02.015.PubMedCrossRef
9.
go back to reference Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996, 78: 47-55. 10.1006/clin.1996.0007.PubMedCrossRef Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996, 78: 47-55. 10.1006/clin.1996.0007.PubMedCrossRef
10.
go back to reference Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA: High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999, 179: 295-302. 10.1086/314597.PubMedCrossRef Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA: High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999, 179: 295-302. 10.1086/314597.PubMedCrossRef
11.
go back to reference Maes P, Clement J, Groeneveld PH, Colson P, Huizinga TW, Van Ranst M: Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol. 2006, 19: 558-564. 10.1089/vim.2006.19.558.PubMedCrossRef Maes P, Clement J, Groeneveld PH, Colson P, Huizinga TW, Van Ranst M: Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol. 2006, 19: 558-564. 10.1089/vim.2006.19.558.PubMedCrossRef
12.
go back to reference Markotic A: [Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome]. Acta Med Croatica. 2003, 57: 407-414.PubMed Markotic A: [Immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome]. Acta Med Croatica. 2003, 57: 407-414.PubMed
13.
go back to reference Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK: Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection. J Virol. 2011 Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK: Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection. J Virol. 2011
14.
go back to reference Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis. 1996, 173: 38-43. 10.1093/infdis/173.1.38.PubMedCrossRef Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis. 1996, 173: 38-43. 10.1093/infdis/173.1.38.PubMedCrossRef
15.
go back to reference Makela S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 2004, 43: 809-816. 10.1053/j.ajkd.2003.12.044.PubMedCrossRef Makela S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 2004, 43: 809-816. 10.1053/j.ajkd.2003.12.044.PubMedCrossRef
16.
go back to reference Saksida A, Wraber B, Avsic-Zupanc T: Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis. 2011, 11: 142-10.1186/1471-2334-11-142.PubMedPubMedCentralCrossRef Saksida A, Wraber B, Avsic-Zupanc T: Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis. 2011, 11: 142-10.1186/1471-2334-11-142.PubMedPubMedCentralCrossRef
17.
go back to reference Ulrich R, Meisel H, Schutt M, Schmidt J, Kunz A, Klempa B, Niedrig M, Pauli G, Kruger DH, Koch J: [Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004, 47: 661-670.PubMedCrossRef Ulrich R, Meisel H, Schutt M, Schmidt J, Kunz A, Klempa B, Niedrig M, Pauli G, Kruger DH, Koch J: [Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004, 47: 661-670.PubMedCrossRef
18.
go back to reference Tersago K, Verhagen R, Vapalahti O, Heyman P, Ducoffre G, Leirs H: Hantavirus outbreak in Western Europe: reservoir host infection dynamics related to human disease patterns. Epidemiol Infect. 2010, 139: 381-390.PubMedCrossRef Tersago K, Verhagen R, Vapalahti O, Heyman P, Ducoffre G, Leirs H: Hantavirus outbreak in Western Europe: reservoir host infection dynamics related to human disease patterns. Epidemiol Infect. 2010, 139: 381-390.PubMedCrossRef
19.
20.
go back to reference Hofmann J, Meisel H, Klempa B, Vesenbeckh SM, Beck R, Michel D, Schmidt-Chanasit J, Ulrich RG, Grund S, Enders G, Kruger DH: Hantavirus outbreak, Germany, 2007. Emerg Infect Dis. 2008, 14: 850-852. 10.3201/eid1405.071533.PubMedPubMedCentralCrossRef Hofmann J, Meisel H, Klempa B, Vesenbeckh SM, Beck R, Michel D, Schmidt-Chanasit J, Ulrich RG, Grund S, Enders G, Kruger DH: Hantavirus outbreak, Germany, 2007. Emerg Infect Dis. 2008, 14: 850-852. 10.3201/eid1405.071533.PubMedPubMedCentralCrossRef
21.
go back to reference Braun N, Haap M, Overkamp D, Kimmel M, Alscher MD, Lehnert H, Haas CS: Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases. Nephrol Dial Transplant. 2010, 25: 2997-3003. 10.1093/ndt/gfq118.PubMedCrossRef Braun N, Haap M, Overkamp D, Kimmel M, Alscher MD, Lehnert H, Haas CS: Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases. Nephrol Dial Transplant. 2010, 25: 2997-3003. 10.1093/ndt/gfq118.PubMedCrossRef
22.
go back to reference Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C: Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis. 2011, 30: 685-690. 10.1007/s10096-010-1141-6.PubMedPubMedCentralCrossRef Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C: Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis. 2011, 30: 685-690. 10.1007/s10096-010-1141-6.PubMedPubMedCentralCrossRef
23.
go back to reference Eckerle I, Heussel CP: Fever, acute renal failure and pulmonary edema. Nephrology Dialysis Transplant Plus. 2011, 310-312. Eckerle I, Heussel CP: Fever, acute renal failure and pulmonary edema. Nephrology Dialysis Transplant Plus. 2011, 310-312.
24.
go back to reference Linderholm M, Billstrom A, Settergren B, Tarnvik A: Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection. 1992, 20: 263-266. 10.1007/BF01710791.PubMedCrossRef Linderholm M, Billstrom A, Settergren B, Tarnvik A: Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection. 1992, 20: 263-266. 10.1007/BF01710791.PubMedCrossRef
25.
go back to reference Linderholm M, Sandstrom T, Rinnstrom O, Groth S, Blomberg A, Tarnvik A: Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis. 1997, 25: 1084-1089. 10.1086/516093.PubMedCrossRef Linderholm M, Sandstrom T, Rinnstrom O, Groth S, Blomberg A, Tarnvik A: Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis. 1997, 25: 1084-1089. 10.1086/516093.PubMedCrossRef
26.
go back to reference Zoller L, Yang S, Gott P, Bautz EK, Darai G: Use of recombinant nucleocapsid proteins of the Hantaan and nephropathia epidemica serotypes of Hantaviruses as immunodiagnostic antigens. J Med Virol. 1993, 39: 200-207. 10.1002/jmv.1890390305.PubMedCrossRef Zoller L, Yang S, Gott P, Bautz EK, Darai G: Use of recombinant nucleocapsid proteins of the Hantaan and nephropathia epidemica serotypes of Hantaviruses as immunodiagnostic antigens. J Med Virol. 1993, 39: 200-207. 10.1002/jmv.1890390305.PubMedCrossRef
27.
go back to reference Zoller L, Faulde M, Meisel H, Ruh B, Kimmig P, Schelling U, Zeier M, Kulzer P, Becker C, Roggendorf M, et al: Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 1995, 14: 305-313. 10.1007/BF02116523.PubMedCrossRef Zoller L, Faulde M, Meisel H, Ruh B, Kimmig P, Schelling U, Zeier M, Kulzer P, Becker C, Roggendorf M, et al: Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 1995, 14: 305-313. 10.1007/BF02116523.PubMedCrossRef
28.
go back to reference Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Pauli G, Ulrich R, Kruger DH: Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clin Vaccine Immunol. 2006, 13: 1349-1357. 10.1128/CVI.00208-06.PubMedPubMedCentralCrossRef Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Pauli G, Ulrich R, Kruger DH: Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clin Vaccine Immunol. 2006, 13: 1349-1357. 10.1128/CVI.00208-06.PubMedPubMedCentralCrossRef
29.
go back to reference Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N, Ulrich RG: Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev. 2008, 225: 163-189. 10.1111/j.1600-065X.2008.00694.x.PubMedCrossRef Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N, Ulrich RG: Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev. 2008, 225: 163-189. 10.1111/j.1600-065X.2008.00694.x.PubMedCrossRef
30.
go back to reference Schilling S, Emmerich P, Klempa B, Auste B, Schnaith E, Schmitz H, Kruger DH, Gunther S, Meisel H: Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol. 2007, 45: 3008-3014. 10.1128/JCM.02573-06.PubMedPubMedCentralCrossRef Schilling S, Emmerich P, Klempa B, Auste B, Schnaith E, Schmitz H, Kruger DH, Gunther S, Meisel H: Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol. 2007, 45: 3008-3014. 10.1128/JCM.02573-06.PubMedPubMedCentralCrossRef
31.
go back to reference Kruger DH, Ulrich R, Lundkvist AA: Hantavirus infections and their prevention. Microbes Infect. 2001, 3: 1129-1144. 10.1016/S1286-4579(01)01474-5.PubMedCrossRef Kruger DH, Ulrich R, Lundkvist AA: Hantavirus infections and their prevention. Microbes Infect. 2001, 3: 1129-1144. 10.1016/S1286-4579(01)01474-5.PubMedCrossRef
32.
go back to reference Kramski M, Meisel H, Klempa B, Kruger DH, Pauli G, Nitsche A: Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing. Clin Chem. 2007, 53: 1899-1905. 10.1373/clinchem.2007.093245.PubMedCrossRef Kramski M, Meisel H, Klempa B, Kruger DH, Pauli G, Nitsche A: Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing. Clin Chem. 2007, 53: 1899-1905. 10.1373/clinchem.2007.093245.PubMedCrossRef
33.
go back to reference Outinen TK, Makela SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, Porsti IH, Syrjanen JT, Mustonen JT: The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis. 2010, 10: 132-10.1186/1471-2334-10-132.PubMedPubMedCentralCrossRef Outinen TK, Makela SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, Porsti IH, Syrjanen JT, Mustonen JT: The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis. 2010, 10: 132-10.1186/1471-2334-10-132.PubMedPubMedCentralCrossRef
34.
go back to reference Jiang H, Wang PZ, Zhang Y, Xu Z, Sun L, Wang LM, Huang CX, Lian JQ, Jia ZS, Li ZD, Bai XF: Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology. 2008, 380: 52-59. 10.1016/j.virol.2008.07.002.PubMedCrossRef Jiang H, Wang PZ, Zhang Y, Xu Z, Sun L, Wang LM, Huang CX, Lian JQ, Jia ZS, Li ZD, Bai XF: Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology. 2008, 380: 52-59. 10.1016/j.virol.2008.07.002.PubMedCrossRef
35.
go back to reference Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, Morikawa S: Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch Virol. 2004, 149: 1279-1292.PubMedCrossRef Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, Morikawa S: Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch Virol. 2004, 149: 1279-1292.PubMedCrossRef
36.
go back to reference Terajima M, Hayasaka D, Maeda K, Ennis FA: Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?. Immunol Lett. 2007, 113: 117-120. 10.1016/j.imlet.2007.08.003.PubMedPubMedCentralCrossRef Terajima M, Hayasaka D, Maeda K, Ennis FA: Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?. Immunol Lett. 2007, 113: 117-120. 10.1016/j.imlet.2007.08.003.PubMedPubMedCentralCrossRef
37.
go back to reference Makela S, Hurme M, Ala-Houhala I, Mustonen J, Koivisto AM, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant. 2001, 16: 1368-1373. 10.1093/ndt/16.7.1368.PubMedCrossRef Makela S, Hurme M, Ala-Houhala I, Mustonen J, Koivisto AM, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant. 2001, 16: 1368-1373. 10.1093/ndt/16.7.1368.PubMedCrossRef
38.
go back to reference Borges AA, Donadi EA, Campos GM, Moreli ML, de Sousa RL, Saggioro FP, de Figueiredo GG, Badra SJ, Deghaide NH, Figueiredo LT: Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil. Arch Virol. 2010, 155: 971-975. 10.1007/s00705-010-0655-7.PubMedCrossRef Borges AA, Donadi EA, Campos GM, Moreli ML, de Sousa RL, Saggioro FP, de Figueiredo GG, Badra SJ, Deghaide NH, Figueiredo LT: Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil. Arch Virol. 2010, 155: 971-975. 10.1007/s00705-010-0655-7.PubMedCrossRef
39.
go back to reference Moutschen P, Bourhaba M, Frippiat F, Giot JB, Meuris C, Leonard P, Moutschen M: A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. J Clin Virol. 2011, 50: 247-248. 10.1016/j.jcv.2010.11.016.PubMedCrossRef Moutschen P, Bourhaba M, Frippiat F, Giot JB, Meuris C, Leonard P, Moutschen M: A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. J Clin Virol. 2011, 50: 247-248. 10.1016/j.jcv.2010.11.016.PubMedCrossRef
40.
go back to reference Borges AA, Campos GM, Moreli ML, Moro Souza RL, Saggioro FP, Figueiredo GG, Livonesi MC, Moraes Figueiredo LT: Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect. 2008, 10: 1150-1157. 10.1016/j.micinf.2008.06.006.PubMedCrossRef Borges AA, Campos GM, Moreli ML, Moro Souza RL, Saggioro FP, Figueiredo GG, Livonesi MC, Moraes Figueiredo LT: Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect. 2008, 10: 1150-1157. 10.1016/j.micinf.2008.06.006.PubMedCrossRef
41.
go back to reference Groeneveld PH, Colson P, Kwappenberg KM, Clement J: Increased production of nitric oxide in patients infected with the European variant of hantavirus. Scand J Infect Dis. 1995, 27: 453-456. 10.3109/00365549509047045.PubMedCrossRef Groeneveld PH, Colson P, Kwappenberg KM, Clement J: Increased production of nitric oxide in patients infected with the European variant of hantavirus. Scand J Infect Dis. 1995, 27: 453-456. 10.3109/00365549509047045.PubMedCrossRef
42.
go back to reference Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986, 136: 3916-3920.PubMed Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986, 136: 3916-3920.PubMed
43.
go back to reference Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol. 2002, 76: 444-449. 10.1128/JVI.76.1.444-449.2002.PubMedPubMedCentralCrossRef Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol. 2002, 76: 444-449. 10.1128/JVI.76.1.444-449.2002.PubMedPubMedCentralCrossRef
44.
go back to reference Easterbrook JD, Zink MC, Klein SL: Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc Natl Acad Sci USA. 2007, 104: 15502-15507. 10.1073/pnas.0707453104.PubMedPubMedCentralCrossRef Easterbrook JD, Zink MC, Klein SL: Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc Natl Acad Sci USA. 2007, 104: 15502-15507. 10.1073/pnas.0707453104.PubMedPubMedCentralCrossRef
45.
go back to reference Schountz T, Prescott J, Cogswell AC, Oko L, Mirowsky-Garcia K, Galvez AP, Hjelle B: Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci USA. 2007, 104: 15496-15501. 10.1073/pnas.0707454104.PubMedPubMedCentralCrossRef Schountz T, Prescott J, Cogswell AC, Oko L, Mirowsky-Garcia K, Galvez AP, Hjelle B: Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci USA. 2007, 104: 15496-15501. 10.1073/pnas.0707454104.PubMedPubMedCentralCrossRef
Metadata
Title
Cytokine expression during early and late phase of acute Puumala hantavirus infection
Authors
Mahmoud Sadeghi
Isabella Eckerle
Volker Daniel
Ulrich Burkhardt
Gerhard Opelz
Paul Schnitzler
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2011
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-12-65

Other articles of this Issue 1/2011

BMC Immunology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine